UCLA scientists develop tiny implantable device to fight against cancer

Image credit: nci via Unsplash

A recent study published in Nature Biomedical Engineering has revealed promising results from laboratory studies testing a tiny implantable device called a SymphNode in cancer treatment. These experiments showed the device’s ability to induce remission in tumors, eliminate metastasis, and prevent the growth of new tumors, and extend the survival of mice. Developed by an interdisciplinary research team at UCLA, the compact design of the SymphNode allows for precise, localized treatment, marking a promising step forward in cancer treatment.

Source

“Tiny Implantable Device Designed by UCLA Scientists Helps Kill Cancer.” UCLA Health, www.uclahealth.org/news/tiny-implantable-device-designed-ucla-scientists-helps-kill#:~:text=The%20researchers%20also%20found%20that,more%20than%2040%25%20of%20cases. Accessed 27 Dec. 2023.